with artificial intelligence (AI) leading the charge. For gene therapy developers, every key milestone significantly influences long-term success and the timeline for commercialisation.
To understand the workings of DNA in relation to disease, scientists at Los Alamos National Laboratory have developed the first multimodal deep learning model of its kind, EPBDxDNABERT-2, capable of ...